BioMarin Pharmaceutical
BMRN
#1094
Rank
$16.71 B
Marketcap
$88.61
Share price
0.99%
Change (1 day)
-3.16%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - P/B ratio

P/B ratio as of March 2024 : 3.38

According to BioMarin Pharmaceutical's latest financial reports the company has a price-to-book ratio of 3.38.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

BioMarin Pharmaceutical - P/B ratio (from 2001 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-313.67-12.21%
2022-12-314.189.88%
2021-12-313.80-1.92%
2020-12-313.88-20.39%
2019-12-314.87-4.78%
2018-12-315.11-8.28%
2017-12-315.588.26%
2016-12-315.15-26.93%
2015-12-317.05-20.1%
2014-12-318.8217.21%
2013-12-317.5323.5%
2012-12-316.0919.97%
2011-12-315.0822.28%
2010-12-314.15-29.53%
2009-12-315.89-8.22%
2008-12-316.42-64.93%
2007-12-3118.343.5%
2006-12-3112.8-223.42%
2005-12-31-10.370.54%
2004-12-31-6.06-243.53%
2003-12-314.229.79%
2002-12-313.85

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
1.50-55.44%๐Ÿ‡ซ๐Ÿ‡ท France
14.0 314.55%๐Ÿ‡บ๐Ÿ‡ธ USA
1.35-60.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.07-131.56%๐Ÿ‡บ๐Ÿ‡ธ USA
21.9 547.77%๐Ÿ‡บ๐Ÿ‡ธ USA
4.94 46.42%๐Ÿ‡บ๐Ÿ‡ธ USA